StockData

Electromedical Technologies, Inc (EMED) stock

EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.00+0.00 (+9900.00%)

Close on Oct 19, 2026Market cap $68.10KP/E –Yield –

How the market prices Electromedical Technologies

Each ratio against its own distribution since 2020, from month-end prices and the figures reported at the time

Electromedical Technologies trades at 0.1× its earnings, against a median of 0.4× since 2020 — cheaper than 99% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2020, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2020

Median 0.4×, today 0.1×

What Electromedical Technologies keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin75.1%vs 55.4%
Operating margin-109.6%vs -5.17%
EBITDA margin-109.6%vs -2.67%
Net margin-182.0%vs -10.3%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-295.1%vs -12.2%

How hard the assets work

Revenue per dollar of assets1.62vs 0.58
Inventory turns a year9.47vs 2.23
Revenue per employee$153.67Kvs $328.95K
Profit per employee-$279.72Kvs -$48.85K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $34.81K.

Cash and short-term investments$34.81K
EBITDA, trailing twelve months-$1.01M

Leverage and liquidity

Current ratio0.07vs 2.50
Quick ratio0.01vs 1.55

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

5 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

EMEDS&P 500
PeriodEMEDS&P 500DifferenceEMED per yearS&P 500 per year
1 month0.0%+0.6%−0.6 pts
3 months0.0%+3.4%−3.4 pts
Year to date-50.0%+13.3%−63.3 pts
1 year0.0%+16.6%−16.6 pts
3 years-85.7%+86.4%−172.1 pts-47.7%+23.1%
5 years-99.9%+81.9%−181.8 pts-76.4%+12.7%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Jan 30, 2026.

0M EMED shares were sold short on Jan 30, 2026. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Jan 30, 2026107,222–6,377,9421.0
Dec 31, 202599,100–12,730,6211.0
Sep 30, 2025150,000–7,223,6081.0
Jul 15, 2025697–26,276,5031.0
May 30, 202520,000-80.0%110,942,6181.0
May 15, 2025100,000–115,845,0851.0
Apr 15, 2025138,415–485,977,0691.0
Mar 14, 2025500,000–15,291,5571.0
Dec 13, 2024190,000-8.4%52,275,6111.0
Nov 29, 2024207,500–7,402,1511.0
Oct 15, 202431,800-55.7%26,716,1421.0
Sep 30, 202471,800–17,409,6871.0

Every measure, in full

33 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2024
Share price as of
–

Share statisticsIndustry

Float
855M
38M
Shares Held by Insiders
0.00%
10.3%

MarginsIndustry

Gross Margin
75.1%
55.4%
Operating Margin
-109.6%
-5.17%
Profit Margin
-182.0%
-10.3%
EBITDA Margin
-109.6%
-2.67%

Returns on capitalIndustry

Return on Assets (ROA)
-295.1%
-12.2%

Financial positionIndustry

Current Ratio
0.07
2.50
Quick Ratio
0.01
1.55
Interest Coverage
-4.38
-1.68

GrowthIndustry

Revenue Growth (3Y CAGR)
22.3%
7.08%

EfficiencyIndustry

Asset Turnover
1.62
0.58
Inventory Turnover
9.47
2.23
Revenue Per Employee
$153.67K
$328.95K
Profits Per Employee
-$279.72K
-$48.85K
Employee Count
6
193

Income statement (TTM)Industry

Revenue
$922.01K
$104.77M
Gross Profit
$692.23K
$61.99M
Operating Income
-$1.01M
-$3.82M
Net Income
-$1.68M
-$6.23M
EBITDA
-$1.01M
-$2.02M
EPS (Diluted)
-$0.00
-$0.07

Balance sheetIndustry

Net Cash (Debt)
$34.81K
$3.73M
Net Cash Per Share
$0.00
$0.28
Equity (Book Value)
-$4.00M
$63.83M
Book Value Per Share
-$0.00
$3.03
Tangible Book Value
-$4.00M
$10.75M
Working Capital
-$4.05M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
-$131.21K
-$463.66K

Taxes and interestIndustry

Interest Expense
$230.88K
$5.33M

Scores and fair valueIndustry

Piotroski F-Score
5
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?